by Peter Mas Mollinedo – Improvements in diagnostics and medical treatments mean the number of patients living with cancer is increasing around the world. The World Health Organization… read more.
by Peter Mas Mollinedo reporting on the presentation by Dominique Elias, Gustave-Roussy Institute, Paris, France. – Aggressive complete cytoreductive surgery (CCRS) in combination with hyperthermic intraperitoneal chemotherapy (HIPEC)… read more.
LM Wiltink, Leiden University Medical Center, the Netherlands; Hans-Joachim Schmoll, Martin Luther University Halle – Wittenberg, Germany. A unique 14-year follow-up study from the universities of Leiden in… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Anti-clotting agent helps reduce the risk of intraprocedural events during percutaneous coronary intervention.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. In a clinical trial, a self-expanding transcatheter aortic valve met the key… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with… read more.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Length of infection increases risk for atherosclerosis. HIV infection, not antiretroviral therapy… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Clinical trial finds that a strategy of using of a bare metal stent in the… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI,… read more.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Results of the EUROMAX trial presented at TCT 2013; findings simultaneously published… read more.
by Bruce Sylvester – Combined use of three DMARDs (disease-modifying antirheumatic drugs) for recent-onset rheumatoid arthritis (RA) is more effective than methotrexate monotherapy, researchers reported at the American… read more.
Children with juvenile idiopathic arthritis (JIA) undergoing early and aggressive combination drug therapy achieve clinical inactive disease more quickly than with less aggressive therapy, researchers reported at the… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
